|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12P 21/02 | (2006.01) |
| C07K 16/00 | (2006.01) | ||
| C12P 21/00 | (2006.01) | ||
| C12N 5/00 | (2006.01) |
| (11) | Number of the document | 2837680 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14187232.5 |
| Date of filing the European patent application | 2012-06-29 | |
| (97) | Date of publication of the European application | 2015-02-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
| (46) | Date of publication of the claims translation | 2020-07-10 |
| (30) | Number | Date | Country code |
| 201161503737 P | 2011-07-01 | US |
| (72) |
Follstad, Brian, D., US
McCoy, Rebecca, E., US
Morris, Arvia, E., US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive Thousand Oaks, California 91320,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Žinduolių ląstelių kultūra |
| MAMMALIAN CELL CULTURE |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 14 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-11-06 |